APPILI THERAPEUTICS INC by Appili Therapeutics Inc. (APLIF) Stock Price, Quote, News & History

SPY772.04+0.09%QQQ745.40+0.12%BTC/USD84,340.29−0.11%DIA517.72+0.04%GLD393.05−0.09%TLT79.38+0.08%

APPILI THERAPEUTICS INC by Appili Therapeutics Inc. (APLIF) Stock Price, Quote, News & History

APLIFOTCPK

Trade with Public

$0.00942

0.000374.09%

At close: Sep 25, 5:00 PM EST

OverviewNews Financials Sentiment Compare

Key Statistics

Open

$0.01

Volume / Avg.

400.00 / 28.23K

Day Range

$0.01 - $0.01

52 Wk Range

0.01 - 0.03

Market Cap

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

2.41

Recent Appili Therapeutics Inc News

APLIF: Advancing Multiple Programs to Combat Infectious Diseases…

By David Bautz, PhD OTC:APLIF | TSX:APLI.TO READ THE FULL APLIF RESEARCH REPORT

Zacks Small Cap Research

APLIF: New Late Stage Program to Treat Cutaneous Leishmaniasis…

Bautz: By David Bautz, PhD OTC:APLIF | TSX:APLI.TO READ THE FULL APLIF RESEARCH REPORT

Zacks Small Cap Research

APLIF: U.S. DoD to Provide Over US$10 Million in Funding for ATI-1701…

By David Bautz, PhD OTC:APLIF | TSX:APLI.TO READ THE FULL APLIF RESEARCH REPORT

Zacks Small Cap Research

APLIF: PRESECO Trial Unsuccessful in COVID-19…

By David Bautz, PhD OTC:APLIF | TSX:APLI.TO READ THE FULL APLIF RESEARCH REPORT

Zacks Small Cap Research

Partner Content

A Deep Dive Into COVID Oral Treatments — What Does the Atea Failure Mean for Oral Antivirals?

Photo by Danilo Alvesd on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga.

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-1.37M

Investing Cash Flow (TTM)

Financing Cash Flow (TTM)

363.93K

Free Cash Flow (TTM)

-1.37M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

-1.00M

Valuation Metrics

Enterprise Value

$10.26M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

4.65

PB Ratio (TTM)

Earnings Yield % (TTM)

-235.65%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

-$0.10

Company Debt

Total Debt

$13.33M

LT Debt

$640.30K

LT Debt Issuance (TTM)

$175.00K

LT Debt Repayment (TTM)

-$32.58K

Total Cash

$138.68K

Debt to Equity

Issuance of Debt (TTM)

$142.42K

Repayment of Debt (TTM)

-$32.58K

Key Statistics

Open

$0.01

Volume / Avg.

400.00 / 28.23K

Day Range

$0.01 - $0.01

52 Wk Range

0.01 - 0.03

Market Cap

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

2.41

About

Sector

Health Care

Industry

Pharmaceuticals

Appili Therapeutics Inc is an infectious disease biopharmaceutical company that is purposefully built, portfolio-driven, and people-focused to fulfill its mission of solving life-threatening infections. By systematically identifying urgent infections...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

FAQ

How do I buy APPILI THERAPEUTICS INC by Appili Therapeutics Inc. (APLIF) stock?

You can purchase shares of APPILI THERAPEUTICS INC by Appili Therapeutics Inc. (OTCPK:APLIF) through any online brokerage.

View our list of the best stock brokerages

Who are APPILI THERAPEUTICS INC by Appili Therapeutics Inc. (APLIF) competitors?

There are no as such competitors for APPILI THERAPEUTICS INC by Appili Therapeutics Inc..

What is the forecast, or price target, for APPILI THERAPEUTICS INC by Appili Therapeutics Inc. (APLIF) stock?

There is no analysis for APPILI THERAPEUTICS INC by Appili Therapeutics Inc. to provide a consensus price target.

What is the current price for APPILI THERAPEUTICS INC by Appili Therapeutics Inc. (APLIF)?

The stock price for APPILI THERAPEUTICS INC by Appili Therapeutics Inc. (OTCPK: APLIF) is $0.00942 last updated September 25, 2026 at 1:39 PM EDT.

Does APPILI THERAPEUTICS INC by Appili Therapeutics Inc. (APLIF) pay a dividend?

There are no upcoming dividends for APPILI THERAPEUTICS INC by Appili Therapeutics Inc..

When is APPILI THERAPEUTICS INC by Appili Therapeutics Inc. (OTCPK:APLIF) reporting earnings?

APPILI THERAPEUTICS INC by Appili Therapeutics Inc. does not have any upcoming earnings scheduled.

Is APPILI THERAPEUTICS INC by Appili Therapeutics Inc. (APLIF) going to split?

There is no upcoming split for APPILI THERAPEUTICS INC by Appili Therapeutics Inc..

What sector and industry does APPILI THERAPEUTICS INC by Appili Therapeutics Inc. (APLIF) operate in?

APPILI THERAPEUTICS INC by Appili Therapeutics Inc. is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCPK.